Prothena | PRTA - Operating Profit

Stock Price
8.85
Daily Change
0.07 0.80%
Monthly
-2.75%
Yearly
-40.12%
Q1 Forecast
8.55

Prothena reported $-39.76M in Operating Profit for its fiscal quarter ending in September of 2025.





Operating Profit Change Date
Acadia Pharmaceuticals USD 35.76M 3.38M Sep/2025
Agios Pharmaceuticals USD -116.87M 10.19M Sep/2025
ALKERMES USD 89.08M 3.9M Sep/2025
Alnylam Pharmaceuticals USD -29.96M 13.76M Sep/2025
Amgen USD 3.96B 464M Dec/2025
Biogen USD 659.6M 192.2M Sep/2025
BioMarin Pharmaceutical USD -31.69M 308.58M Sep/2025
Exelixis USD 256.36M 42.78M Sep/2025
Incyte USD 431.31M 120.49M Sep/2025
Ionis Pharmaceuticals USD -160.18M 300.02M Sep/2025
MacroGenics USD 18.64M 55.4M Sep/2025
Neurocrine Biosciences USD 239.3M 93.7M Sep/2025
Prothena USD -39.76M 12.25M Sep/2025
Regeneron Pharmaceuticals USD 898.6M 211.3M Dec/2025
Ultragenyx Pharmaceutical USD -170.89M 22.68M Sep/2025
Vertex Pharmaceuticals USD 1.24B 84.6M Sep/2025